DCM

DAFNA Capital Management Portfolio holdings

AUM $405M
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+24.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$10.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
111
New
Increased
Reduced
Closed

Top Buys

1
+$2.83M
2
+$2.52M
3
+$2.08M
4
IMMU
Immunomedics Inc
IMMU
+$1.89M
5
SYRE icon
Spyre Therapeutics
SYRE
+$1.7M

Top Sells

1
+$2.49M
2
+$2.21M
3
+$1.89M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$1.37M
5
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
+$1.32M

Sector Composition

1 Healthcare 71.02%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-47,500
102
– –
-81,402
103
– –
-140,275
1 2 3 4
5